Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001246345 | SCV001419692 | uncertain significance | Carnitine palmitoyl transferase 1A deficiency | 2021-08-31 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine with threonine at codon 19 of the CPT1A protein (p.Ile19Thr). The isoleucine residue is moderately conserved and there is a moderate physicochemical difference between isoleucine and threonine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with CPT1A-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV003284123 | SCV003958635 | uncertain significance | Inborn genetic diseases | 2023-04-07 | criteria provided, single submitter | clinical testing | The c.56T>C (p.I19T) alteration is located in exon 2 (coding exon 1) of the CPT1A gene. This alteration results from a T to C substitution at nucleotide position 56, causing the isoleucine (I) at amino acid position 19 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001246345 | SCV002092981 | uncertain significance | Carnitine palmitoyl transferase 1A deficiency | 2021-05-18 | no assertion criteria provided | clinical testing |